Psoriasis Podcast - Hand and Foot Psoriasis - No. 5 - March 2007

Welcome to Psoriasis Cure Now Podcast #5. Our topic is hand and foot psoriasis, a particularly challenging type of psoriasis that is difficult to live with and difficult to treat.

First, we speak with Craig Leonardi, MD, a board-certified dermatologist in private practice in St. Louis, Missouri, and a Clinical Assistant Professor of Dermatology at St. Louis University. He recently conducted a study of a biologic treatment for hand and foot psoriasis.After that, we speak with Tim Savage of Virginia. He has psoriasis on his hands, which are central to his work as a sign language interpreter. We talk to Tim about his experiences treating his hand psoriasis.

You can listen to this month's program right here:

You can also listen to it via iTunes; or you can subscribe to our podcast series via these tabs: or

We have more information on hand and foot psoriasis treatment options.

Several news items are also discussed in this podcast. Here are links to additional information on those items:

* Seventy novel treatments being studied for psoriasis.

* Government funding of psoriasis research increased in 2006.

* Psoriasis legislation introduced in Congress.

* Our Latest News page is the #1 place on the internet for breaking news (and a touch of commentary) on psoriasis and psoriatic arthritis.

* Psoriasis Volunteer sign-up page: help us fight for a cure!

The closing music in this podcast is an excerpt from Fingers & Toes from the debut album, Happy Songs, by Maryland-based, kid-friendly band Milkshake.

If you would like to comment or sound off on this podcast, or suggest future podcast topics, you can email us at podcast AT psoriasis-cure-now.org, or call our automated comment line at 240-450-2665. Note that we may include your comments (but not your name) on our website or play your message in a future podcast, unless you tell us not to. We look forward to hearing from you.

This podcast is made possible by unrestricted educational grants from Amgen and Genentech, as well as contributions from listeners like you.

Thanks for your support, and thanks for listening.